SinoFresh Nasal Spray To Be Evaluated In Initial H1N1 Animal Pilot Study To Assess Ability To Kill Or Reduce Virus Levels

    VENICE, FL, September 21, 2009 /24-7PressRelease/ -- David R. Olund, President of SinoFresh Healthcare Products, Inc., says, "the company is initiating this preliminary study in response to widespread concern over the continued spread of the H1N1 virus in the U.S. and Internationally. SinoFresh's topical antiseptic nasal spray has demonstrated in previous studies the ability to reduce the presence of a wide range of airborne pathogens in the nasal and sinus cavities and we believe that the product may have a favorable effect on the H1N1 virus. Our goal is that the SinoFresh product line will ultimately emerge as a cost effective consumer and institutional option for broad based airborne disease prevention."

Chief Medical advisor, Dr. Michael Stampar says "Our goal is to demonstrate that a topical antiseptic nasal spray can prevent infection, reduce severity or reduce the duration of viral shedding. Previously positive in-vitro and in-vivo studies that included a number of widely known airborne pathogens, as well as MRSA, give the Company reason to be optimistic in my opinion."

SinoFresh HealthCare Products, Inc. is a privately held exclusive global marketer of innovative upper respiratory system therapies including its lead product, SinoFresh Homeopathic Nasal Spray, a hygienic cleansing spray that kills germs and removes other nasal-sinus irritants. The Company uses broad-spectrum antiseptic approaches to reduce the load of viral, bacterial, and fungal organisms present in the sinus and nasal cavities that are believed to be the cause of sinusitis and other pathogenesis of the mouth, nose, and throat.

Website: http://www.sinofreshproducts.com

# # #